As shown in Fig. 1C, the c-Met, Sox2 and Oct4 mRNA expressions in CD133+ cells were significantly higher than those in CD133− cells, which suggested that CD133+ cells have characteristics of cancer stem cells. The gene discussed is PROM1; the disease is cancer.